Katherine Matthews

1.7k total citations
17 papers, 656 citations indexed

About

Katherine Matthews is a scholar working on Oncology, Immunology and Epidemiology. According to data from OpenAlex, Katherine Matthews has authored 17 papers receiving a total of 656 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Immunology and 5 papers in Epidemiology. Recurrent topics in Katherine Matthews's work include CAR-T cell therapy research (6 papers), Cytomegalovirus and herpesvirus research (5 papers) and Immune Cell Function and Interaction (5 papers). Katherine Matthews is often cited by papers focused on CAR-T cell therapy research (6 papers), Cytomegalovirus and herpesvirus research (5 papers) and Immune Cell Function and Interaction (5 papers). Katherine Matthews collaborates with scholars based in Australia, United Kingdom and United States. Katherine Matthews's co-authors include Rajiv Khanna, Corey Smith, Sweera Rehan, Leone Beagley, Michelle A. Neller, Pauline Crooks, David A. Price, David Walker, Kristin Ladell and Andrea Schuessler and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Katherine Matthews

17 papers receiving 641 citations

Peers

Countries citing papers authored by Katherine Matthews

Since Specialization

Citations

This map shows the geographic impact of Katherine Matthews's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine Matthews with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine Matthews more than expected).

Fields of papers citing papers by Katherine Matthews

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine Matthews. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine Matthews. The network helps show where Katherine Matthews may publish in the future.

Co-authorship network of co-authors of Katherine Matthews

This figure shows the co-authorship network connecting the top 25 collaborators of Katherine Matthews. A scholar is included among the top collaborators of Katherine Matthews based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherine Matthews. Katherine Matthews is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	SARS-CoV-2-specific T cells generated for adoptive immunotherapy are capable of recognizing multiple SARS-CoV-2 variants 2022 ·PLoS Pathogens ·Archana Panikkar, Katie E. Lineburg, Jyothy Raju, Keng Yih Chew, George Ambalathingal, Sweera Rehan, Srividhya Swaminathan, Pauline Crooks, Laëtitia Le Texier, Leone Beagley, Shannon E. Best, Matthew D. Solomon, Katherine Matthews, Sriganesh Srihari, Michelle A. Neller, Kirsty R. Short, Rajiv Khanna, Corey Smith	17
2	Complete response to PD-1 blockade following EBV-specific T-cell therapy in metastatic nasopharyngeal carcinoma 2021 ·npj Precision Oncology ·Corey Smith, Margaret McGrath, Michelle A. Neller, Katherine Matthews, Pauline Crooks, Laëtitia Le Texier, Benedict Panizza, Sandro Porceddu, Rajiv Khanna	25
3	Autologous CMV-specific T cells are a safe adjuvant immunotherapy for primary glioblastoma multiforme 2020 ·Journal of Clinical Investigation ·Corey Smith, Katie E. Lineburg, José Paulo Martins, George Ambalathingal, Michelle A. Neller, (unknown), Katherine Matthews, Sweera Rehan, Pauline Crooks, Archana Panikkar, Leone Beagley, Laëtitia Le Texier, Sriganesh Srihari, David Walker, Rajiv Khanna	49
4	Rapid detection of SARS‐CoV‐2‐specific memory T‐cell immunity in recovered COVID‐19 cases 2020 ·Clinical & Translational Immunology ·Katie E. Lineburg, Sriganesh Srihari, (unknown), Srividhya Swaminathan, Archana Panikkar, Jyothy Raju, Pauline Crooks, George Ambalathingal, José Paulo Martins, Katherine Matthews, Michelle A. Neller, Rajiv Khanna, Corey Smith	20
5	Pretransplant Cytomegalovirus-Specific Cellular Immunity and Risk of Viral Reactivation Following Lung Transplantation: A Prospective Cohort Study 2020 ·The Journal of Infectious Diseases ·(unknown), Katie E. Lineburg, Pauline Crooks, Sweera Rehan, Katherine Matthews, Michelle A. Neller, George Ambalathingal, Debottam Sinha, (unknown), Peter Hopkins, Daniel C. Chambers, Rajiv Khanna, Corey Smith	10
6	T cell repertoire remodeling following post-transplant T cell therapy coincides with clinical response 2019 ·Journal of Clinical Investigation ·Corey Smith, Dillon Corvino, Leone Beagley, Sweera Rehan, Michelle A. Neller, Pauline Crooks, Katherine Matthews, Matthew D. Solomon, Laëtitia Le Texier, Scott B. Campbell, Ross S. Francis, Daniel C. Chambers, Rajiv Khanna	15
7	Framework engineering to produce dominant T cell receptors with enhanced antigen-specific function 2019 ·Nature Communications ·Sharyn Thomas, Fiyaz Mohammed, Rogier M. Reijmers, Annemarie Woolston, (unknown), Alan Kennedy, David R. Stirling, Angelika Holler, Louisa Green, David T. Jones, Katherine Matthews, David A. Price, Benny Chain, Mirjam H.M. Heemskerk, Emma Morris, Benjamin E. Willcox, Hans J. Stauss	43
8	Impact of pre‐therapy glioblastoma multiforme microenvironment on clinical response to autologous CMV‐specific T‐cell therapy 2019 ·Clinical & Translational Immunology ·David Walker, (unknown), (unknown), Michelle A. Neller, Katherine Matthews, John M. Nicholls, Corey Smith, Rajiv Khanna	11
9	Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosis 2018 ·JCI Insight ·Michael P. Pender, Peter A. Csurhes, Corey Smith, (unknown), Michelle A. Neller, Katherine Matthews, Leone Beagley, Sweera Rehan, Pauline Crooks, Tracey Hopkins, Stefan Blum, (unknown), Zara A. Ioannides, Andrew Swayne, Blake T. Aftab, (unknown), Scott R. Burrows, (unknown), Alan Coulthard, Rajiv Khanna	110
10	Impact of diabetes in the Friedreich ataxia clinical outcome measures study 2017 ·Annals of Clinical and Translational Neurology ·(unknown), Jennifer Farmer, Susan B. Perlman, Martin B. Delatycki, George Wilmot, Katherine Matthews, Grace Yoon, (unknown), S. H. Subramony, Theresa A. Zesiewicz, David R. Lynch, Shana E. McCormack	13
11	Activation‐Induced Killer Cell Immunoglobulin‐like Receptor 3DL2 Binding to HLA–B27 Licenses Pathogenic T Cell Differentiation in Spondyloarthritis 2015 ·Arthritis & Rheumatology ·Anna Ridley, Hiroko Hatano, Isabel Wong‐Baeza, Jacqueline Shaw, Katherine Matthews, Hussein Al‐Mossawi, Kristin Ladell, David A. Price, Paul Bowness, Simon Kollnberger	38
12	Autologous T-cell Therapy for Cytomegalovirus as a Consolidative Treatment for Recurrent Glioblastoma 2014 ·Cancer Research ·Andrea Schuessler, Corey Smith, Leone Beagley, Glen M. Boyle, Sweera Rehan, Katherine Matthews, Linda Jones, Tania Crough, Vijayendra Dasari, Kerenaftali Klein, (unknown), Hamish Alexander, David Walker, Rajiv Khanna	147
13	β-Cell–Specific CD8 T Cell Phenotype in Type 1 Diabetes Reflects Chronic Autoantigen Exposure 2014 ·Diabetes ·Ania Skowera, Kristin Ladell, James E. McLaren, Garry Dolton, Katherine Matthews, Emma Gostick, Deborah Kronenberg‐Versteeg, Martin Eichmann, (unknown), Susanne Heck, Jake Powrie, Polly J. Bingley, Colin Dayan, John J. Miles, Andrew K. Sewell, David A. Price, Mark Peakman	87
14	Progression of carcinogen‐induced fibrosarcomas is associated with the accumulation of naïve CD4+ T cells via blood vessels and lymphatics 2013 ·International Journal of Cancer ·Beatrice Ondondo, Emma Jones, James P. Hindley, (unknown), Kathryn Smart, Hayley Bridgeman, Katherine Matthews, Kristin Ladell, David A. Price, David G. Jackson, Andrew Godkin, Ann Ager, Awen Gallimore	6
15	T-cell Receptor-optimized Peptide Skewing of the T-cell Repertoire Can Enhance Antigen Targeting 2012 ·Journal of Biological Chemistry ·Julia Makinde, Mathew Clement, David K. Cole, Emily S.J. Edwards, Kristin Ladell, John J. Miles, Katherine Matthews, Anna Fuller, Katy A. Lloyd, Florian Madura, Garry Dolton, Johanne M. Pentier, Anna Lissina, Emma Gostick, Tiffany K. Baxter, Brian M. Baker, P.J. Rizkallah, David A. Price, Linda Wooldridge, Andrew K. Sewell	37
16	CD8+ TCR Repertoire Formation Is Guided Primarily by the Peptide Component of the Antigenic Complex 2012 ·The Journal of Immunology ·(unknown), (unknown), Ilka Hoof, John J. Miles, Nening M. Nanlohy, Kristin Ladell, Katherine Matthews, Vanessa Venturi, Ingrid M. M. Schellens, José A. M. Borghans, Can Keşmir, David A. Price, Debbie van Baarle	23
17	Long-Term Lipid Profiles with Isradipine and Hydrochlorothiazide Treatment in Elderly Hypertensive Patients 1990 ·Journal of Cardiovascular Pharmacology ·Gerald H. Stein, Katherine Matthews, (unknown), (unknown), Larry M. Lopez, (unknown)	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact